To test this, we calculated enrichment of genetic variants at LSD1-bound sites for association with type 2 diabetes (T2D) (48), diabetes-related quantitative phenotypes (49–52), and other complex traits and diseases for calibration (see Methods). The gene discussed is KDM1A; the disease is type 2 diabetes mellitus.